03 August 2018
Visiongain has launched a new pharma report Clinical Trial Supply Market Report and Logistics Market for Pharma 2018-2028: Clinical Trial Manufacturing, Clinical Trial Logistics and Distributions, Clinical Trial Supply Chain Management, Clinical Trial Packaging, Clinical Trial Cold Chain Logistics
Pharmaceutical service providers offer a wide variety of services to drug developers and other clinical trial sponsors that form a vital part of the clinical trial supply chain. For the purposes of this report, visiongain identified three main sectors of the clinical trial supply and logistics market:
• Clinical trial material manufacturing and packaging services
• Clinical trial logistics and distribution services
• Other supply chain management services
Across the pharmaceutical industry, outsourcing has become an increasingly popular way to cut costs across all aspects of the business, by reducing internal capacity - in terms of sites maintained and headcount.
The lead analyst of the report commented “Clinical trial globalisation will continue to drive growth of this market, stimulating demand for international distribution services. Globalisation will generate complex trial supply chains, requiring greater planning and logistics support.
Technological advancements will also drive the growth in clinical trial supply and logistics market, providing efficient planning and real-time data analysis to improve supply chains mid-trial. Drug pooling for multi-trial programmes will drive the demand for regional depot network with strong transport networks to trial sites.”
Leading companies featured in the report include World Courier, DHL, Marken, FedEx, Movianto, Catalent, Patheon, Almac Group, Parexel International, Fisher Clinical Services, Packaging Coordinators Inc.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to email@example.com or call her on +44 (0) 207 336 6100
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports cusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
Growing demand for cost-effective drugs; rising prevalence of chronic diseases; mounting investment in drug R&D by biopharmaceutical companies; new product launches and rising acceptance of biosimilars in North America region are some of the major factors that propel the biosimilars market growth.
25 November 2020
Currently, the ATMP market is at a nascent stage and is expected to flourish during near future owing to increasing research and development activities and rising use of ATMP therapy products in treatment areas with low or no alternative treatment options support the market growth
24 November 2020
Increasing prevalence of cardiovascular diseases is increasing demand of biological imaging reagents for the diagnosis and treatment of cardiovascular diseases due to this reason increasing prevalence of cardiovascular diseases is acting as a driver for biological imaging reagent market.
13 November 2020
Hypertensive is the most common disease around the world. However, number of people suffering from hypertensive has increased very significantly from last few years. Hypertensive can occur due to consumption of tobacco, too much salt (sodium) and little potassium in your diet, alcohol and to people being overweight or obese.